N-Trans-p- Coumaroyltyramine Enhances Indomethacin- and Diclofenac-induced Apoptosis Through Endoplasmic Reticulum Stress-dependent Mechanism in MCF-7 Cells

Anticancer Res. 2022 Apr;42(4):1833-1844. doi: 10.21873/anticanres.15659.

Abstract

Background/aim: The anticancer potential of indomethacin and diclofenac has been reported against several types of cancer cells. In this study, we investigated the enhancement effect of a coumaric acid derivative found in some Piper plants, N-trans-p-coumaroyltyramine (TCT) on indomethacin and diclofenac cytotoxicity in breast cancer cells.

Materials and methods: MCF-7 and mitoxantrone-resistant MCF-7 (MCF-7/MX) cancer cells were treated with indomethacin or diclofenac in the presence of TCT for 48 h. Cell viability, apoptosis, mitochondrial function and signaling proteins were assayed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Hoechst 33342, tetramethyl-rhodamine-ethyl-ester and western blot analysis, respectively.

Results: Combination treatment resulted in significant reduction of cell viability and mitochondrial membrane potential, whereas the ratio of BCL2-associated X, apoptosis regulator to BCL2 apoptosis regulator, and apoptosis increased. The enhancing effect of TCT was related to reduced nuclear factor-erythroid factor 2-related factor 2/heme oxygenase-1 expression, and increased activation of the protein kinase RNA-like endoplasmic reticulum kinase/eukaryotic initiation factor 2 alpha/activating transcription factor 4/C/EBP homologous protein signaling pathways.

Conclusion: TCT in combination with indomethacin or diclofenac promoted endoplasmic reticulum stress-dependent apoptosis in breast cancer cells.

Keywords: ER stress; N-Trans-p-coumaroyltyramine; NSAIDs; apoptosis; breast cancer cells; potentiation.

MeSH terms

  • Apoptosis
  • Coumaric Acids* / pharmacology
  • Diclofenac* / pharmacology
  • Endoplasmic Reticulum Stress
  • Humans
  • Indomethacin / pharmacology
  • MCF-7 Cells

Substances

  • Coumaric Acids
  • N-(4-hydroxy-beta-phenethyl)-4-hydroxycinnamide
  • Diclofenac
  • Indomethacin